Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000289133

Medchemexpress LLC Aurantiamide acetate | 56121-42-7 | MFCD17214814 | 99.9% | 444.52 g·mol⁻¹ | C27H28N2O4 | 10 MG
SDP

Catalog No. 5000289133
Encompass_Preferred

Aurantiamide acetate is a small-molecule cathepsin inhibitor used as a research reagent with reported anti-inflammatory activity. It inhibits cathepsin L (IC50 12 μM) and cathepsin B (IC50 49 μM), is supplied as a white to off-white solid, and is reported at ~99.9% purity (CAS 56121-42-7).

  • Selective cathepsin L and B inhibitor (IC50 12 μM and 49 μM).
  • Demonstrated anti-inflammatory activity for disease research.
  • High purity suitable for analytical and preclinical use.
  • Soluble in DMSO (50 mg/mL) and formulatable for in vivo dosing.
  • Stable when stored under recommended conditions for powder and solutions.

Catalog No. 50-002-89133 Supplier Medchemexpress LLC Supplier No. HYN290510MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Aurantiamide acetate is a small-molecule cathepsin inhibitor used as a research reagent with reported anti-inflammatory activity. It inhibits cathepsin L (IC50 12 μM) and cathepsin B (IC50 49 μM), is supplied as a white to off-white solid, and is reported at ~99.9% purity (CAS 56121-42-7).

  • Selective cathepsin L and B inhibitor (IC50 12 μM and 49 μM).
  • Demonstrated anti-inflammatory activity for disease research.
  • High purity suitable for analytical and preclinical use.
  • Soluble in DMSO (50 mg/mL) and formulatable for in vivo dosing.
  • Stable when stored under recommended conditions for powder and solutions.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.